Successful Live Birth in Partial Hydatidiform Mole: A Case Report
Case Report
DOI:
https://doi.org/10.55175/cdk.v53i09.2207Keywords:
Case report, intrauterine growth restriction, live birth, oligohydramnios, partial hydatidiform moleAbstract
Introduction: Partial hydatidiform mole (PHM) is a rare form of gestational trophoblastic disease characterized by abnormal trophoblastic proliferation accompanied by the presence of a fetus. Most cases end in miscarriage, while live births are extremely uncommon. Case: A 22-year-old primigravida diagnosed with PHM, intrauterine growth restriction (IUGR), and oligohydramnios underwent cesarean delivery at 35–37 weeks of gestation, resulting in a live female infant (1,750 g; Apgar scores 8/9). The enlarged placenta (1,180 g) was histopathologically confirmed as PHM. The newborn developed hypoglycemia, thrombocytopenia, and hyperbilirubinemia requiring intensive care, while the mother recovered uneventfully with declining β-hCG levels. Discussion: This case is remarkable as such an occurrence is extremely rare, as most PHM pregnancies end in spontaneous abortion during the first or second trimester due to chromosomal abnormalities and placental insufficiency. Postpartum follow-up revealed a gradual decline in β-hCG levels until they returned to normal, indicating the absence of persistent gestational trophoblastic disease. Conclusion: Pregnancies complicated by PHM require multidisciplinary care and close monitoring, including vigilance during the antenatal period, postpartum evaluation, and appropriate neonatal management to prevent and manage potential complications. Although rare and often associated with poor outcomes, PHM with live birth can achieve favorable results.
Downloads
References
Panthi A, Bhattarai M, Katwal S, Bhandari S, Baral R, Bhusal M, et al. Partial molar pregnancy with hydrops fetalis causing intrauterine fetal demise: a case report. Clin Case Rep. 2023;11(10):e8006. doi: 10.1002/ccr3.8006.
Edwin E, Budihastuti UR, Elnita CS. Partial molar pregnancy with live fetus in first trimester: what should we do next. J KedoktSyiah Kuala. 2020;20(2):111–4. doi: 10.24815/jks.v20i2.18505.
Libretti A, Longo D, Faiola S, De Pedrini A, Troìa L, Remorgida V. A twin pregnancy with partial hydatidiform mole and a coexisting normal fetus delivered at term: a case report and literature review. Case Rep Womens Health. 2023;39:e00544. doi: 10.1016/j.crwh.2023.e00544.
Sehiril Kinci O, Kinci MF, Arslaner MO, MirzazadaF, Uncel Melek. Molar pregnancy frequency of abortions in our clinic and pre-diagnosis success. EgeJ Med. 2023;62(4):481–5. doi: 10.19161/etd.1185567.
Attar SNG, Attar SMG. Partial molar pregnancy with a normal live fetus and umbilical cord abnormalities: a novel association with long-term follow-up: a case report. Clin Case Rep. 2021;9(9):e04839. doi: 10.1002/ccr3.4839.
Lubis PN. Efektivitas progesteron oral vagina pada tata laksana abortus imminens. CerminDuniaKedokt. 2023;50(6):339–41. doi: 10.55175/cdk.v50i6.922.
Braga A, Coutinho L, Chagas M, Soares JP, Callado GY, Alevato R, et al. Molar pregnancy: early diagnosis, clinical management, and the role of referral centers. Diagnostics (Basel). 2025;15(15):1953. doi: 10.3390/diagnostics15151953.
Busca A, Parra-Herran C. Placenta: gestational trophoblastic disease-Partial hydatidiform mole [Internet]. Pathology Outlines; 2025 [cited 2025 Sep 3]. Available from: https://www.pathologyoutlines.com/topic/placentaincompletemole.html.
Claudia VP, Gracida LO, Contreras OCO. Mola with partial live fetus 20 weeks pregnancy case report. Int J Fam Community Med. 2020;4(2):44–6.doi: 10.15406/ijfcm.2020.04.00181
Patil BU, Gangane NM, Shivkumar VB. The frequency of hydatidiform mole in a tertiary care hospital from central India. Indian J PatholOncol. 2020;7(1):71–5. doi: 10.18231/j.ijpo.2020.014
Abidi S, Shah T, Abbas S. Delivering a live fetus at 24th gestational week: a case of partial hydatidiform molar pregnancy. GynaecolObstet Case Rep. 2021;7(5):1–4.
Cue L, Farci F, Ghassemzadeh S, Kang M. Hydatidiform mole [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2026 Aug 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459155/.
Hassan HB, Hassan YB, Omar AKA. Molar pregnancy with co-existing viable fetus delivered preterm at 24 weeks gestation: a case report. Int Med Case Rep J. 2023;16:651–4. doi: 10.2147/IMCRJ.S412528.
Im DH, Kim YN, Cho HJ, Kwon MJ, Yoon HK, Kim DH, et al. Prenatal differential diagnosis of placental mesenchymal dysplasia and molar disease with coexistent live twin fetuses. ClinExpObstet Gynecol. 2022;49(11):254. doi: 10.31083/j.ceog4911254.
Saputra R, Azra D, Aswad FM, Nurtanio S. From molar pregnancy, thyrotoxicosis, to pulmonary hypertension: a case report. AndalasObstetGynecol J. 2024;8(1):661–6. doi: 10.25077/aoj.8.1.661-666.2024
Abate AT, Gedefaw GD, Kassahun CW, Kelkay MM. Prevalence and associated factors of thrombocytopenia among neonates in Northwest Amhara region comprehensive specialized hospitals, Ethiopia: a cross sectional study. Sci Rep. 2025;15(1):12610. doi: 10.1038/s41598-025-93042-0.
Giouleka S, Gkiouleka M, Tsakiridis I, Daniilidou A, Mamooulos A, Athanasiadis A, et al. Diagnosis and management of neonatal hypoglycemia: a comprehensive review of guidelines. Children (Basel). 20233;10(7):1220. doi: 10.3390/children10071220.
Putri AR, Arumndari R, Liman N, Suryaningsih PS. Hipoglikemiapersistenpadaneonatusprematur, kecil masa kehamilan (KMK), danberatbadanlahirrendah (BBLR) dariibudenganriwayatpreeklampsiaberat.CerminDuniaKedokt. 2024;51(11):640–3. doi: 10.55175/cdk.v51i11.1019.
Islam MT, Bhuiyan ANH, Shameem M, Sumi SA, Jahan R, Islam MM, et al. Immediate outcome of intrauterine growth restricted infants. Sir Salimullah Med Coll J. 2023;31(1):9–12. doi: 10.3329/ssmcj.v31i1.69334.
Thiono MT, Polanunu MR. Profile of neonatal mortality in dr. M. Haulussy Regional Hospital, Indonesia. Cermin Dunia Kedokt. 2025;52(2):73–7. doi: 10.55175/cdk.v52i2.1247.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Anggia Mayangsari Wardhana

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.






